Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2025 Volume 29 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2025 Volume 29 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease

  • Authors:
    • Kefan Xue
    • Yihan Li
    • Rui Hu
    • Xiao Hu
    • Ran Guo
    • Hongxia Guo
    • Gang Li
  • View Affiliations / Copyright

    Affiliations: Division of Cardiology, Institute of Geriatric Diseases, Hebei General Hospital, Shijiazhuang, Hebei 050000, P.R. China, General Clinical Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Pathophysiology, Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, The Third General Surgery Department, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Anesthesiology, Hebei General Hospital, Shijiazhuang, Hebei 050000, P.R. China
  • Article Number: 126
    |
    Published online on: April 30, 2025
       https://doi.org/10.3892/etm.2025.12876
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The incidence of coronary atherosclerotic heart disease is on the rise, posing a serious threat to public health. Emerging evidence highlights the interplay between systemic inflammation and cardiovascular pathophysiology, suggesting novel diagnostic avenues. The aim of the present study was to evaluate the predictive value of fecal sulfatide and neutrophil‑to‑lymphocyte ratio (NLR), both individually and in combination, for coronary heart disease (CHD). A total of 523 patients diagnosed with CHD at the Cardiovascular Department of Hebei General Hospital (Shijiazhuang, China) from August 2022 to September 2023 were included in the experimental group, along with 198 healthy controls. The CHD group was further subdivided into stable angina pectoris (n=194), unstable angina pectoris (n=134), and acute myocardial infarction (AMI) groups (n=195). Fecal sulfatide and serum NLR levels were measured in both the experimental and control groups, as well as within each CHD subgroup. Multivariate logistic regression was utilized to assess whether these biomarkers serve as independent risk factors for CHD. The predictive value of fecal sulfatide and serum NLR was evaluated using receiver operating characteristic curves. Fecal sulfatide and serum NLR levels were distinctly higher in the CHD group compared with the control group (2.40±0.48 vs. 1.64±0.39 µmol/l and 2.92 vs. 1.65; P<0.05). Patients with AMI had higher NLR levels than those with stable and unstable angina pectoris (5.55 vs. 2.65 and 2.68; P<0.05). Fecal sulfatide levels were also elevated in patients with AMI (2.50±0.44 µmol/l) compared with patients with stable angina pectoris (2.32±0.48 µmol/l). Both fecal sulfatide (AUC=0.899) and NLR (AUC=0.811) exhibited strong predictive accuracy for CHD. When combined, the predictive value (AUC=0.945) was further improved. Elevated levels of fecal sulfatide and serum NLR in patients with CHD revealed that these biomarkers may serve as valuable adjuncts in the diagnosis of CHD. The combined use of these biomarkers enhances the accuracy and reliability of CHD prediction.
View Figures

Figure 1

View References

1 

Hu SS: Writing Committee of the Report on Cardiovascular Health and Diseases in China. Epidemiology and current management of cardiovascular disease in China. J Geriatr Cardiol. 21:387–406. 2024.PubMed/NCBI View Article : Google Scholar

2 

Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, et al: 2024 heart disease and stroke statistics: A report of US and global data from the American heart association. Circulation. 149:e347–e913. 2024.PubMed/NCBI View Article : Google Scholar

3 

Pastena P, Frye JT, Ho C, Goldschmidt ME and Kalogeropoulos AP: Ischemic cardiomyopathy: Epidemiology, pathophysiology, outcomes, and therapeutic options. Heart Fail Rev. 29:287–299. 2024.PubMed/NCBI View Article : Google Scholar

4 

Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ and Han M: Inflammation and atherosclerosis: Signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 7(131)2022.PubMed/NCBI View Article : Google Scholar

5 

Gupta L, Thomas J, Ravichandran R, Singh M, Nag A and Panjiyar BK: Inflammation in cardiovascular disease: A comprehensive review of biomarkers and therapeutic targets. Cureus. 15(e45483)2023.PubMed/NCBI View Article : Google Scholar

6 

Li G, Hu R, Wu HZ and Chen SX: High serum concentration of sulfatide is a risk factor for restenosis in patients with coronary heart disease after percutaneous coronary intervention. Metabolomics (Los Angel). 5(1)2015.

7 

Zahorec R: Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 122:474–488. 2021.PubMed/NCBI View Article : Google Scholar

8 

Li S, Chen H, Zhou L, Cui H, Liang S and Li H: Neutrophil-to-lymphocyte ratio predicts coronary artery lesion severity and long-term cardiovascular mortality in patients with unstable angina pectoris. Acta Cardiol. 77:708–715. 2022.PubMed/NCBI View Article : Google Scholar

9 

Agarwal R, Aurora RG, Siswanto BB and Muliawan HS: The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease. Coron Artery Dis. 33:137–143. 2022.PubMed/NCBI View Article : Google Scholar

10 

Conti CR: Epidemiology, pathophysiology, and therapeutic targets in stable ischemic heart disease. Cardiovasc Innov App. 3:279–283. 2019.

11 

Hara A and Taketomi T: Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit. J Biochem. 109:904–908. 1991.PubMed/NCBI View Article : Google Scholar

12 

Li G, Hu R, Gu J and Wu HZ: Relationship between carotid artery atherosclerosis and sulfatide in hypertensive patients. Genet Mol Res. 14:4840–4846. 2015.PubMed/NCBI View Article : Google Scholar

13 

Li G, Hu R, Guo Y, He L, Zuo Q and Wang Y: Circulating sulfatide, a novel biomarker for ST-segment elevation myocardial infarction. J Atheroscler Thromb. 26:84–92. 2019.PubMed/NCBI View Article : Google Scholar

14 

Inoue T, Taguchi I, Abe S, Abe S, Li G, Hu R, Nakajima T, Hara A, Aoyama T, Kannagi R, et al: Sulfatides are associated with neointimal thickening after vascular injury. Atherosclerosis. 211:291–296. 2010.PubMed/NCBI View Article : Google Scholar

15 

Shimazawa M, Kondo K, Hara H, Nakashima M and Umemura K: Sulfatides, L- and P-selectin ligands, exacerbate the intimal hyperplasia occurring after endothelial injury. Eur J Pharmacol. 520:118–126. 2005.PubMed/NCBI View Article : Google Scholar

16 

Libby P, Ridker PM and Hansson GK: Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol. 54:2129–2138. 2009.PubMed/NCBI View Article : Google Scholar

17 

Silvestre-Roig C, Braster Q, Ortega-Gomez A and Soehnlein O: Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 17:327–340. 2020.PubMed/NCBI View Article : Google Scholar

18 

Hofbauer TM, Ondracek AS and Lang IM: Neutrophil extracellular traps in atherosclerosis and thrombosis. Handb Exp Pharmacol. 270:405–425. 2022.PubMed/NCBI View Article : Google Scholar

19 

Adamstein NH, MacFadyen JG, Rose LM, Glynn RJ, Dey AK, Libby P, Tabas IA, Mehta NN and Ridker PM: The neutrophil-lymphocyte ratio and incident atherosclerotic events: Analyses from five contemporary randomized trials. Eur Heart J. 42:896–903. 2021.PubMed/NCBI View Article : Google Scholar

20 

Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA and Gurm HS: Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 102:653–657. 2008.PubMed/NCBI View Article : Google Scholar

21 

Buonacera A, Stancanelli B, Colaci M and Malatino L: Neutrophil to lymphocyte ratio: An emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 23(3636)2022.PubMed/NCBI View Article : Google Scholar

22 

Zhang S, Diao J, Qi C, Jin J, Li L, Gao X, Gong L and Wu W: Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A meta-analysis. BMC Cardiovasc Disord. 18(75)2018.PubMed/NCBI View Article : Google Scholar

23 

Choi DH, Kobayashi Y, Nishi T, Kim HK, Ki YJ, Kim SS, Park KH, Song H and Fearon WF: Combination of mean platelet volume and neutrophil to lymphocyte ratio predicts long-term major adverse cardiovascular events after percutaneous coronary intervention. Angiology. 70:345–351. 2019.PubMed/NCBI View Article : Google Scholar

24 

Xu N, Tang XF, Yao Y, Zhao X, Chen J, Gao Z, Yang Y, Gao RL, Xu B and Yuan JQ: Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction. Catheter Cardiovasc Interv. 91:551–557. 2018.PubMed/NCBI View Article : Google Scholar

25 

Chen J, Chen MH, Li S, Guo YL, Zhu CG, Xu RX, Zhang Y, Sun J, Qing P, Liu G and Li JJ: Usefulness of the neutrophil-to-lymphocyte ratio in predicting the severity of coronary artery disease: A Gensini score assessment. J Atheroscler Thromb. 21:1271–1282. 2014.PubMed/NCBI View Article : Google Scholar

26 

Dziedzic EA, Gąsior JS, Tuzimek A, Dąbrowski M and Jankowski P: Neutrophil-to-lymphocyte ratio is not associated with severity of coronary artery disease and is not correlated with vitamin D level in patients with a history of an acute coronary syndrome. Biology (Basel). 11(1001)2022.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xue K, Li Y, Hu R, Hu X, Guo R, Guo H and Li G: Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease. Exp Ther Med 29: 126, 2025.
APA
Xue, K., Li, Y., Hu, R., Hu, X., Guo, R., Guo, H., & Li, G. (2025). Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease. Experimental and Therapeutic Medicine, 29, 126. https://doi.org/10.3892/etm.2025.12876
MLA
Xue, K., Li, Y., Hu, R., Hu, X., Guo, R., Guo, H., Li, G."Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease". Experimental and Therapeutic Medicine 29.6 (2025): 126.
Chicago
Xue, K., Li, Y., Hu, R., Hu, X., Guo, R., Guo, H., Li, G."Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease". Experimental and Therapeutic Medicine 29, no. 6 (2025): 126. https://doi.org/10.3892/etm.2025.12876
Copy and paste a formatted citation
x
Spandidos Publications style
Xue K, Li Y, Hu R, Hu X, Guo R, Guo H and Li G: Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease. Exp Ther Med 29: 126, 2025.
APA
Xue, K., Li, Y., Hu, R., Hu, X., Guo, R., Guo, H., & Li, G. (2025). Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease. Experimental and Therapeutic Medicine, 29, 126. https://doi.org/10.3892/etm.2025.12876
MLA
Xue, K., Li, Y., Hu, R., Hu, X., Guo, R., Guo, H., Li, G."Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease". Experimental and Therapeutic Medicine 29.6 (2025): 126.
Chicago
Xue, K., Li, Y., Hu, R., Hu, X., Guo, R., Guo, H., Li, G."Predictive value of fecal sulfatide and neutrophil-to‑lymphocyte ratio in coronary heart disease". Experimental and Therapeutic Medicine 29, no. 6 (2025): 126. https://doi.org/10.3892/etm.2025.12876
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team